Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/35484Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Manning, Brooke | - |
| dc.contributor.author | Hayley, Amie C | - |
| dc.contributor.author | Downey, Luke A | - |
| dc.date | 2024 | - |
| dc.date.accessioned | 2024-09-12T01:01:02Z | - |
| dc.date.available | 2024-09-12T01:01:02Z | - |
| dc.date.issued | 2024-09-02 | - |
| dc.identifier.citation | European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology 2024-09-02; 88 | en_US |
| dc.identifier.issn | 1873-7862 | - |
| dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/35484 | - |
| dc.language.iso | eng | - |
| dc.title | Response to ensuring safety in cannabinoid prescriptions: A call for critical assessment. | en_US |
| dc.type | Journal Article | en_US |
| dc.identifier.journaltitle | European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology | en_US |
| dc.identifier.affiliation | Centre for Mental Health & Brain Sciences, Swinburne University of Technology, Melbourne, Australia. | en_US |
| dc.identifier.affiliation | Institute for Breathing and Sleep | en_US |
| dc.identifier.doi | 10.1016/j.euroneuro.2024.08.513 | en_US |
| dc.type.content | Text | en_US |
| dc.identifier.pubmedid | 39226859 | - |
| dc.description.volume | 88 | - |
| dc.description.startpage | 50 | - |
| item.grantfulltext | none | - |
| item.openairetype | Journal Article | - |
| item.languageiso639-1 | en | - |
| item.fulltext | No Fulltext | - |
| item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
| item.cerifentitytype | Publications | - |
| crisitem.author.dept | Institute for Breathing and Sleep | - |
| Appears in Collections: | Journal articles | |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.